The potential cost to the U.S. government next year of remedying unlawful Medicare Part B drug payment cuts for 340B hospitals could be higher than federal Medicare officials think.
The U.S. Centers for Medicare & Medicaid Services in mid-July put the annual figure at about $1.96 billion. A few days later, a federal advisory board reported that the figure is closer to $2.3 billion—a $340 million difference. Since 2018, the sum typically seen in court documents has been $1.6 billion per year—most recently in a U.S. Supreme Court opinion.
The potential cost to the U.S. government next year of remedying unlawful Medicare Part B drug payment cuts for 340B hospitals could be higher than federal Medicare officials think.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
